Hasjim Bima J, Mohammadi Mohsen, Balbale Salva N, Paukner Mitchell, Banea Therese, Shi Haoyan, Furmanchuk Al'ona, VanWagner Lisa B, Zhao Lihui, Duarte-Rojo Andres, Doll Julianna, Mehrotra Sanjay, Ladner Daniela P
Northwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Northwestern University, Chicago, Illinois.
Center for Engineering and Health, McCormick School of Engineering and Applied Science, Northwestern University, Chicago, Illinois; Department of Industrial Engineering and Management Sciences, McCormick School of Engineering, Northwestern University, Evanston, Illinois.
Clin Gastroenterol Hepatol. 2024 Oct 18. doi: 10.1016/j.cgh.2024.08.044.
BACKGROUND & AIMS: Cirrhosis-related inpatient hospitalizations have increased dramatically over the past decade. We used a longitudinal dataset capturing a large metropolitan area in the United States from 2011 to 2021 to evaluate contemporary hospitalization rates and risk factors among frail patients with cirrhosis.
We conducted a retrospective, longitudinal cohort study using the Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN) database, an electronic health record repository that aggregates de-duplicated data across 7 health care systems in the Chicago metropolitan area, from 2011 to 2021. The primary outcome of our study was the rate of hospitalization encounters. Frailty was defined by the Hospital Frailty Risk Score. Hospitalization rates were reported per 100 patients per year, and a multivariable logistic regression analysis identified predictors of annual hospitalization probability.
During the study period, of 36,971 patients, 16,265 patients (44%) were hospitalized (compensated, 18.4%; decompensated, 81.6%). Hospitalization rates were highest in patients with decompensated cirrhosis, reaching nearly 77.3 hospitalizations/100 patients per year. Hospitalization rates among patients with compensated cirrhosis were also high (14.2 vs 77.3 hospitalization/100 patients per year), with odds of annual hospitalization 3 times (odds ratio, 3.1; 95% confidence interval, 2.9-3.4) as high among compensated patients with intermediate frailty and 5 times (odds ratio, 5.2; 95% confidence interval, 4.5-6.0) as high among those with severe frailty (compared with compensated patients with low frailty).
Compensated and decompensated cirrhosis patients with intermediate to severe frailty face a substantially increased odds of annual hospitalizations compared with those with low frailty. Future work should focus on targeted interventions to incorporate routine frailty screenings into cirrhosis care and to ultimately minimize high hospitalization rates.
在过去十年中,肝硬化相关的住院治疗显著增加。我们使用了一个纵向数据集,该数据集涵盖了2011年至2021年美国一个大都市地区的情况,以评估肝硬化体弱患者的当代住院率和危险因素。
我们使用芝加哥地区以患者为中心的结局研究网络(CAPriCORN)数据库进行了一项回顾性纵向队列研究,该数据库是一个电子健康记录库,汇总了2011年至2021年芝加哥大都市地区7个医疗系统中去重后的数据。我们研究的主要结局是住院就诊率。体弱程度由医院体弱风险评分定义。住院率按每年每100名患者报告,多变量逻辑回归分析确定了年度住院概率的预测因素。
在研究期间,36971名患者中,16265名患者(44%)住院(代偿期,18.4%;失代偿期,81.6%)。失代偿期肝硬化患者的住院率最高,每年每100名患者接近77.3次住院。代偿期肝硬化患者的住院率也很高(每年每100名患者14.2次与77.3次住院),中度体弱的代偿期患者年度住院几率是低体弱代偿期患者的3倍(比值比,3.1;95%置信区间,2.9 - 3.4),重度体弱患者是低体弱代偿期患者的5倍(比值比,5.2;95%置信区间,4.5 - 6.0)。
与低体弱的患者相比,中度至重度体弱的代偿期和失代偿期肝硬化患者年度住院几率大幅增加。未来的工作应侧重于有针对性的干预措施,将常规体弱筛查纳入肝硬化护理,并最终将高住院率降至最低。